Published in Neurosci Lett on January 23, 2015
Adolescent alcohol exposure alters lysine demethylase 1 (LSD1) expression and histone methylation in the amygdala during adulthood. Addict Biol (2016) 0.79
Dendritic spine remodeling following early and late Rac1 inhibition after spinal cord injury: evidence for a pain biomarker. J Neurophysiol (2016) 0.78
A Critical Role of Brain-Derived Neurotrophic Factor in Alcohol Consumption. Biol Psychiatry (2016) 0.77
Adolescent Alcohol Exposure: Burden of Epigenetic Reprogramming, Synaptic Remodeling, and Adult Psychopathology. Front Neurosci (2016) 0.77
Alcohol consumption induces global gene expression changes in VTA dopaminergic neurons. Genes Brain Behav (2015) 0.76
Behavioral Neuroadaptation to Alcohol: From Glucocorticoids to Histone Acetylation. Front Psychiatry (2016) 0.75
Alcohol-Induced Neuroadaptation Is Orchestrated by the Histone Acetyltransferase CBP. Front Mol Neurosci (2017) 0.75
Epigenetic basis of the dark side of alcohol addiction. Neuropharmacology (2017) 0.75
Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms. Am J Drug Alcohol Abuse (2016) 0.75
New Implications for the Melanocortin System in Alcohol Drinking Behavior in Adolescents: The Glial Dysfunction Hypothesis. Front Cell Neurosci (2017) 0.75
Emerging role of epigenetic mechanisms in alcohol addiction. Alcohol Clin Exp Res (2017) 0.75
Chromatin modifications and their function. Cell (2007) 55.98
The language of covalent histone modifications. Nature (2000) 44.92
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (2009) 32.97
A synaptic model of memory: long-term potentiation in the hippocampus. Nature (1993) 29.13
CpG islands in vertebrate genomes. J Mol Biol (1987) 23.16
The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell (1996) 16.57
Eukaryotic cytosine methyltransferases. Annu Rev Biochem (2005) 15.45
DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet (2008) 15.45
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci (2006) 13.32
Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature (1993) 11.54
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell (1989) 11.41
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer (2006) 10.73
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell (2011) 9.16
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (2003) 8.81
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature (1999) 7.72
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature (1995) 7.11
Neurotrophins as synaptic modulators. Nat Rev Neurosci (2001) 7.08
HDAC2 negatively regulates memory formation and synaptic plasticity. Nature (2009) 6.96
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell (1996) 6.96
Recovery of learning and memory is associated with chromatin remodelling. Nature (2007) 6.72
Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron (2006) 6.50
Altered histone acetylation is associated with age-dependent memory impairment in mice. Science (2010) 6.38
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci (2007) 6.26
Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 6.08
Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci (2007) 6.00
Synaptic plasticity: taming the beast. Nat Neurosci (2000) 5.80
Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature (2007) 5.54
CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron (2004) 5.40
Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron (2004) 5.35
New nomenclature for chromatin-modifying enzymes. Cell (2007) 5.34
Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science (2009) 5.24
Addiction and the brain antireward system. Annu Rev Psychol (2008) 5.17
Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell (1989) 5.12
Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci (2010) 5.12
Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron (1998) 5.05
Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron (2006) 4.98
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature (1994) 4.92
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell (1991) 4.90
MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell (2012) 4.56
The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci (1999) 4.37
Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci (2005) 4.36
NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron (2005) 4.35
Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res (1993) 4.30
Alcoholism: allostasis and beyond. Alcohol Clin Exp Res (2003) 4.05
Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron (1998) 3.95
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci (2003) 3.67
Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science (1989) 3.47
Decoding the epigenetic language of neuronal plasticity. Neuron (2008) 3.23
Metaplasticity: tuning synapses and networks for plasticity. Nat Rev Neurosci (2008) 3.19
Antidepressant actions of histone deacetylase inhibitors. J Neurosci (2009) 3.17
Activity-dependent decrease in NMDA receptor responses during development of the visual cortex. Science (1992) 3.17
Subunit-specific NMDA receptor trafficking to synapses. Neuron (2002) 3.16
A critical period for long-term potentiation at thalamocortical synapses. Nature (1995) 3.06
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol (2010) 2.94
Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev (2009) 2.82
NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci (1993) 2.76
The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci (2008) 2.73
An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature (2012) 2.67
Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation. Neuron (2001) 2.67
Dynorphin, stress, and depression. Brain Res (2009) 2.45
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci U S A (2008) 2.37
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol (2011) 2.28
Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci (2008) 2.27
Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res (1993) 2.27
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics (2010) 2.26
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) (2010) 2.19
Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories. Cell (2014) 2.18
Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron (2002) 2.17
In vivo cocaine experience generates silent synapses. Neuron (2009) 2.11
Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J Neurosci (2004) 2.04
CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04
From genome to epigenome. Hum Mol Genet (2005) 2.03
Myosin-Va facilitates the accumulation of mRNA/protein complex in dendritic spines. Curr Biol (2006) 2.02
Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res (2010) 2.01
Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci (2004) 2.00
Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry (2010) 1.98
Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron (2013) 1.86
Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron (1993) 1.84
Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology (2009) 1.84
Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol (2003) 1.81
Extended amygdala and basal forebrain. Ann N Y Acad Sci (2003) 1.80
Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J (2003) 1.80
Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci (2013) 1.77
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem (2012) 1.74
Chronic ethanol induces synaptic but not extrasynaptic targeting of NMDA receptors. J Neurosci (2004) 1.67
Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci (2004) 1.67
Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int J Dev Biol (2009) 1.66
TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron (2013) 1.64
The CREB/CREM transcription factors negatively regulate early synaptogenesis and spontaneous network activity. J Neurosci (2009) 1.63
CaMKII binding to GluN2B is critical during memory consolidation. EMBO J (2012) 1.62
Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging (2008) 1.60
Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol (2011) 1.58
Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron (1995) 1.56
NMDA receptor subunit composition controls synaptogenesis and synapse stabilization. Proc Natl Acad Sci U S A (2011) 1.52
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci (2012) 1.52
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci (2007) 1.52